Business / Finance

RSS

Ensign acquires real estate assets of Orem Rehabilitation & Nursing Center

The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.

4 Jan 2012

Bionovo enters $5M securities purchase agreement with Socius

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.

4 Jan 2012

Quest Diagnostics to acquire S.E.D. Medical Labs

S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.

From Quest Diagnostics 4 Jan 2012

Landec second quarter revenues increase 16% to $81.6 million

Landec Corporation, today reported results for the second quarter and first half of fiscal year 2012. Revenues for the second quarter of fiscal year 2012 increased 16% to $81.6 million compared to revenues of $70.2 million for the second quarter of fiscal year 2011.

4 Jan 2012

iCAD enters $15M debt facility agreement with Deerfield Management

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it has entered into a five year, $15 million debt facility agreement with Deerfield Management Company LP, a leading healthcare investment fund.

3 Jan 2012

Accelrys announces acquisition of VelQuest

Accelrys, Inc., a leading scientific enterprise research and development software and services company, today announced that it has acquired privately-held VelQuest Corporation for $35 million in an all-cash transaction.

3 Jan 2012

Regeneron, Genentech enter non-exclusive license and partial settlement agreement for EYLEA

Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.

3 Jan 2012

Cutera to purchase assets of IRIDEX' global aesthetic business

Cutera, Inc. and IRIDEX Corporation today announced that the companies have entered into a binding agreement for Cutera to purchase certain assets of IRIDEX' global aesthetic business for approximately $5.1 million.

3 Jan 2012

MedPro completes acquisition of Princeton

Medical Protective Company (MedPro), a Berkshire Hathaway subsidiary, announced today that it has completed the acquisition of Princeton Insurance Company (Princeton) from Medical Liability Mutual Insurance Company.

3 Jan 2012

Artimplant to take over responsibility for sales of Artelon CMC Spacer

With effect from January 1, 2012, Artimplant will take over responsibility for sales of Artelon® CMC Spacer, previously handled by the licensee SBi. This is an integral part of Artimplant's focus on reinforcing its presence on the very important US market.

3 Jan 2012

Lundbeck invests in Ossianix to focus on biotherapeutics for CNS disorders

Ossianix, Inc. today announced a strategic investment by H. Lundbeck A/S in the form of a Convertible Promissory Note. The proceeds from Lundbeck's investment is expected to allow Ossianix to generate biopharmaceuticals for the treatment of nervous system disorders by utilizing Ossianix's proprietary single domain antibody platform modeled on the shark vNAR structure.

3 Jan 2012

Anytime Fitness to open clubs in the Middle East

Anytime Fitness, the fastest-growing fitness club chain in the world, will soon open its first club in the Middle East. The first of several Anytime Fitness clubs in the State of Qatar opened on January 1, 2012.

2 Jan 2012

Lucid closes underwritten public offering

Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.

31 Dec 2011

RBCC: 2012 could turn out to be better for the global biotechnology sector

With strong growth predicted for the biotech and pharmaceuticals industry in 2012, emerging biotech firm Rainbow Coral Corp. anticipates a prosperous new year ahead.

31 Dec 2011

China's revised Foreign Investment Catalogue 2011 moves healthcare service sectors to 'permitted' category

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, comments on the newly issued Foreign Investment Catalogue 2011 revision which moved healthcare service sectors to "permitted" from "restricted" category.

31 Dec 2011

Additional financing to fund Advaxis' cervical cancer trials

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.

31 Dec 2011

Golden Meditech continues share repurchase program

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.

31 Dec 2011

Chengdu Tianyin receives approval for renewed High Tech Enterprise status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.

30 Dec 2011

AMT raises € 2.5 million through private placement

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the Company has raised € 2.5 million in new equity by means of a private placement to three of its existing shareholders: Forbion Capital Partners, Gilde Healthcare Partners and Advent Venture Partners.

30 Dec 2011

Alexion to acquire 100% of capital stock of Enobia

Alexion Pharmaceuticals, Inc. and Enobia Pharma Corp. today announced that the companies have signed a definitive agreement under which Alexion will acquire 100% of the capital stock of Enobia.

29 Dec 2011